Description
Introduction Of Herlapsa 250mg Tablet:
Herlapsa 250mg Tablet is a targeted anti-cancer medicine used, in combination with other cancer medicines such as capecitabine, in the treatment of HER2-positive advanced or metastatic breast cancer.
Herlapsa 250mg Tablet should be taken on an empty stomach, at least one hour before or one hour after a meal, at the same time every day. Your doctor will decide what dose is necessary and how long you need to take it, depending on your medical condition and the other medicines it is combined with. You should take it exactly as your doctor has advised, and swallow the tablet whole with a glass of water without breaking, crushing, or chewing it. If you miss a dose, take it as soon as you remember, unless it is close to your next dose; do not double the dose.
Diarrhea and fatigue are among the most common effects of this medicine. Your doctor may advise regular monitoring of your heart function and liver enzymes while you are on treatment. Inform your doctor immediately if you notice upper stomach pain, itching, dark urine, pale stools, or yellowing of the skin or eyes, as this medicine can rarely cause serious liver toxicity.
Uses Of Herlapsa 250mg Tablet:
- HER2-positive advanced or metastatic breast cancer
Benefits Of Herlapsa 250mg Tablet:
HER2-positive breast cancer
Some breast cancers grow because their cells produce an excess amount of a protein called human epidermal growth factor receptor 2 (HER2), which drives the growth and multiplication of cancer cells. Herlapsa 250mg Tablet works by inhibiting the excess production of this HER2 protein, which stops the uncontrolled growth of cancer cells and triggers their programmed cell death, helping control the disease in patients who have already received prior breast cancer treatment.
Side effects of Herlapsa 250mg Tablet:
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Common side effects of Herlapsa:
- Diarrhea
- Fatigue
- Nausea
- Rash
- Indigestion
- Loss of appetite
- Headache
- Vomiting
- Dry skin
- Muscle pain (myalgia)
Mechanism Of Action Of Herlapsa 250mg Tablet:
Herlapsa Tablet contains Lapatinib, an anti-cancer medication that works against both the HER2 (human epidermal growth factor receptor 2) and EGFR (epidermal growth factor receptor) proteins, which are responsible for the excessive proliferation of cancer cells. By inhibiting these receptors, Herlapsa blocks the downstream signalling pathways that drive cancer cell growth, ultimately triggering the death of cancer cells.

Reviews
There are no reviews yet.